Shivani Chib | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award

Published on by Forensic Scientist

Ms. Shivani Chib | Pharmacology, Toxicology and Pharmaceutical Science | Women Researcher Award

Central University of Punjab | India

Ms. Shivani Chib is an emerging researcher in the field of pharmacology, specializing in neurodegenerative diseases with a particular focus on Parkinson’s disease and the therapeutic potential of phytoconstituents. Currently pursuing her Ph.D. at the Central University of Punjab, Bathinda, she has contributed extensively through high-impact publications, innovative patents, international presentations, and active peer-reviewing for reputed journals. With multiple national and international awards, she stands out as a dedicated woman researcher committed to advancing pharmacological science and drug discovery.

Professional Profile

Scopus

Google Scholar

Education

Ms. Shivani Chib is currently pursuing her doctoral research in Pharmacology at the Central University of Punjab, Bathinda, under the guidance of Dr. Randhir Singh. Her Ph.D. research centers on Parkinson’s disease and the therapeutic potential of bioactive phytoconstituents, reflecting her dedication to translational research in neuropharmacology. Before her doctoral studies, she completed her Master of Pharmacy in Pharmacology from ISF College of Pharmacy, where she excelled academically and carried out research in experimental pharmacology. Her academic journey began with a Bachelor of Pharmacy in Pharmaceutical Sciences from Sri Sai College of Pharmacy. This progression in higher education reflects not only her intellectual growth but also her determination to specialize in pharmacology and contribute to the field of neuroscience.

Experience

Her professional journey as a researcher began during her postgraduate studies, where she worked as a Research Scholar and focused on understanding drug mechanisms and neuroprotective agents. Currently, as a Ph.D. Research Scholar at the Central University of Punjab, she is engaged in cutting-edge research on Parkinson’s disease, with particular emphasis on dopaminergic neuronal death and the role of phytochemicals such as luteolin and wogonin. She has also contributed as a reviewer for multiple Springer Nature journals, a role that reflects her expertise and recognition in the scientific community. Her active engagement in national and international conferences, combined with her innovative experimental approaches, illustrates her wide-ranging experience in both research and academic settings.

Research Interest

Her research interests revolve around neuropharmacology, neurodegenerative disorders, natural product-based drug discovery, and cognitive impairments associated with aging. She has a deep focus on elucidating the mechanisms of dopaminergic neuronal death in Parkinson’s disease and identifying bioactive phytoconstituents like luteolin and wogonin as potential therapeutic agents. Additionally, her work extends to exploring CNS toxicity of chemotherapeutics, marine functional foods, metabolic syndromes, and the cross-talk between central nervous and cardiovascular systems.

Awards and Recognitions

Ms. Shivani Chib has received numerous awards and recognitions throughout her career, including Best Working Model Award, Best Poster Awards at national and international conferences, and the prestigious GPAT fellowship. She has been awarded multiple international travel grants, including from the Movement Disorder Society and the Anusandhan National Research Foundation, enabling her to present her work globally, including at conferences in the USA and Japan. She has also received certificates of excellence in peer reviewing from Springer Nature and BP International. Her innovation in neuroscience is further highlighted by her registered patents on novel laboratory apparatuses, reflecting her inventive approach to experimental pharmacology.

Publications

Ms. Shivani Chib has published widely in reputed international journals, with her contributions cited in several scholarly works. Selected publications include:

Title: Unveiling the interplay of AMPK/SIRT1/PGC-1α axis in brain health: Promising targets against aging and NDDs
Journal: Ageing Research Reviews
Published on: 2024
Citation: 49

Title: Manganese and related neurotoxic pathways: A potential therapeutic target in neurodegenerative diseases
Journal: Neurotoxicology and Teratology
Published on: 2022
Citation: 35

Title: Unlocking the therapeutic potential of natural stilbene: exploring pterostilbene as a powerful ally against aging and cognitive decline
Journal: Ageing Research Reviews
Published on: 2023
Citation: 21

Title: Treatment of diabetic complications: do flavonoids holds the keys?
Journal: Critical Reviews in Food Science and Nutrition
Published on: 2024
Citation: 16

Title: Paradigms and success stories of natural products in drug discovery against neurodegenerative disorders (NDDs)
Journal: Current Neuropharmacology
Published on: 2024
Citation: 15

Title: Microbiota-brain-gut-Axis relevance to Parkinson’s disease: potential therapeutic effects of probiotics
Journal: Current Pharmaceutical Design
Published on: 2022
Citation: 11

Title: Role of flavonoids in mitigating the pathological complexities and treatment hurdles in Alzheimer’s disease
Journal: Phytotherapy Research
Published on: 2025
Citation: 10

Conclusion

Ms. Shivani Chib has established herself as a promising woman researcher in pharmacology through her strong academic background, impactful publications, innovative patents, and global recognitions. Her work in exploring the therapeutic applications of phytoconstituents against neurodegenerative disorders has the potential to open new pathways for safer and more effective treatments. With her commitment to excellence, interdisciplinary approach, and growing global presence, she exemplifies the qualities of a future leader in pharmacological sciences. She is therefore highly deserving of the Women Researcher Award, which would further empower her to continue contributing to scientific progress and global healthcare solutions.

Christopher Reilly | Toxicology | Best Researcher Award

Published on by Forensic Scientist

Dr. Christopher Reilly | Toxicology | Best Researcher Award

Professor | University of Utah | United States

Dr. Christopher A. Reilly is a renowned pharmacologist and toxicologist at the University of Utah. As a professor and director of the Center for Human Toxicology, he has made significant contributions to understanding toxicological mechanisms, particularly involving TRP channels and environmental pollutants. With an extensive career in research, teaching, and mentoring, Dr. Reilly is a leader in the field, dedicated to advancing pharmacological sciences and improving public health.

Profile

Google Scholar

Scopus

Strengths for the Awards

  • Academic and Research Excellence:
    Dr. Reilly has a distinguished academic background with a Ph.D. in Toxicology and over 25 years of research experience. His tenure as a professor and leadership roles, such as Director of the Center for Human Toxicology, underscore his expertise and impact in his field.
  • Extensive Publication and Research Funding:
    Dr. Reilly has secured substantial research funding from prestigious institutions, including NIH, DOD, and NSF. His work covers critical topics such as air pollution, pharmacokinetics, TRP channels, and toxicology. His projects have garnered over $10 million in research funding, demonstrating his ability to lead impactful and high-value research.
  • Recognized Contributions:
    He has received multiple honors, including the Gordon Research Conference Travel Awards and Colgate-Palmolive Post-Doctoral Fellowship, reflecting the significance of his contributions to toxicology. His publications have been featured in high-impact journals, with several being highlighted as “Manuscript Highlights” and “Cover Articles.”
  • Mentorship and Academic Service:
    Dr. Reilly has mentored numerous students and fellows, several of whom have received significant awards and fellowships. He also contributes to academic governance, serving on multiple committees, including search committees, graduate councils, and retention and promotion committees.

Education 🎓

Dr. Reilly’s academic journey began at the University of Utah, where he earned a B.S. in Biology with emphases in Biochemistry, Molecular Biology, Ecology, and Evolution, and a minor in Chemistry (1994). He then pursued his Ph.D. in Toxicology at Utah State University (1999). Following his doctorate, he completed a prestigious postdoctoral fellowship in Pharmacology and Toxicology at the University of Utah, under the mentorship of Dr. Dennis J. Crouch and Dr. Garold S. Yost.

Experience 🏢

Dr. Reilly has built a distinguished career at the University of Utah, where he currently serves as Professor and Director of the Center for Human Toxicology. Since joining in 1999 as a postdoctoral fellow, he has held numerous roles, including Associate Director and Research Assistant Professor. His career highlights include mentoring in the Pediatric Clinical Pharmacology Program and conducting pioneering research in toxicology and pharmacology.

Research Interests Toxicology 🔬

Dr. Reilly’s research focuses on the toxicological mechanisms mediated by TRP channels, the impact of air pollution on health, and pharmacokinetics. His work delves into the interface of environmental toxicants and human physiology, with a particular emphasis on understanding molecular pathways for therapeutic interventions.

Awards and Honors 🏅

Dr. Reilly has received numerous accolades, including the 2001 Colgate-Palmolive Post-Doctoral Fellowship and the Society of Toxicology’s Domestic ToxScholar Visitor recognition in 2020-2021. He was also inducted as a Fellow of the Academy of Toxicological Sciences in 2023. His research publications have frequently been highlighted as “Featured Articles” or “Cover Articles,” reflecting their impact on the scientific community.

Publications 📚

  • Capsaicinoids cause inflammation and epithelial cell death through activation of vanilloid receptors
    Authors: CA Reilly, JL Taylor, DL Lanza, BA Carr, DJ Crouch, GS Yost
    Year: 2003
    Citations: 236
  • Quantitative analysis of capsaicinoids in fresh peppers, oleoresin capsicum and pepper spray products
    Authors: CA Reilly, DJ Crouch, GS Yost
    Year: 2001
    Citations: 194
  • Peroxidase substrates stimulate the oxidation of hydralazine to metabolites which cause single-strand breaks in DNA
    Authors: CA Reilly, SD Aust
    Year: 1997
    Citations: 189
  • Determination of capsaicin, dihydrocapsaicin, and nonivamide in self-defense weapons by liquid chromatography–mass spectrometry and liquid chromatography–tandem mass spectrometry
    Authors: CA Reilly, DJ Crouch, GS Yost, AA Fatah
    Year: 2001
    Citations: 179
  • Human lung epithelial cells express a functional cold-sensing TRPM8 variant
    Authors: AS Sabnis, M Shadid, GS Yost, CA Reilly
    Year: 2008
    Citations: 173
  • A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda
    Authors: JD Phillips, HA Bergonia, CA Reilly, MR Franklin, JP Kushner
    Year: 2007
    Citations: 172
  • Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells
    Authors: CA Reilly, WJ Ehlhardt, DA Jackson, P Kulanthaivel, AE Mutlib, RJ Espina, …
    Year: 2003
    Citations: 151
  • Measurement of lipid peroxidation
    Authors: CA Reilly, SD Aust
    Year: 1999
    Citations: 147
  • Metabolism of capsaicinoids by P450 enzymes: a review of recent findings on reaction mechanisms, bio-activation, and detoxification processes
    Authors: CA Reilly, GS Yost
    Year: 2006
    Citations: 123
  • Increased transcription of cytokine genes in human lung epithelial cells through activation of a TRPM8 variant by cold temperatures
    Authors: AS Sabnis, CA Reilly, JM Veranth, GS Yost
    Year: 2008
    Citations: 114

Conclusion ✨

Dr. Christopher A. Reilly exemplifies leadership and innovation in toxicology research, education, and mentorship. His dedication to unraveling the complexities of toxicological mechanisms and environmental health impacts has made a lasting impact in academia and beyond. As a mentor, researcher, and professor, Dr. Reilly continues to inspire the next generation of scientists and contribute significantly to public health initiatives.